Ophthalmic trauma is a leading cause of unilateral blindness in the United States with a devasting impact on both individuals and society. Currently, there is no dedicated conference to ophthalmic trauma in the United States, and the American Society of Ophthalmic Trauma Annual Meeting fills a critical gap in education for medical students, residents, fellows and ophthalmologists of all subspecialties in both private and academic practices.
At the conclusion of this activity, participants will be better able to:
• Formulate an evidence-based approach to ophthalmic trauma management
• Describe the up-to-date clinical diagnosis and treatment of ophthalmic trauma in open-globe injuries, anterior and posterior segment management of complications of open-globe injuries, diagnosis and management of orbital and adnexal injuries, and unique characteristics of pediatric ophthalmic injuries
• Indicate the cutting-edge scientific discoveries in ophthalmic trauma management
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Columbia University Vagelos College of Physicians and Surgeons and The American Society of Ophthalmic Trauma. The Columbia University Vagelos College of Physicians and Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Columbia University Vagelos College of Physicians and Surgeons designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™.
Acknowledgment
This activity is supported by an independent educational grant from
Alcon Vision, LLC
Disclosure
All those involved with the planning and delivery of this education will disclose all financial relationships in the past 24 months with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. For each financial relationship, disclosure will include the name of the ineligible company and the nature of the financial relationship(s).
Rupesh Agrawal, MD, MMed, FRCS
None
James Auran, MD
None
Richard Blanch, BSc(Hons), MBChB(Hons), MRCS(Ed), FRCOphth, PhD
None
Kara Cavuoto, MD
None
David F. Chang, MD
Consultant/Equity owner
Beyeonics Surgical, Inc. Centricity, Forsight Vision6 Inc., ForSight Robotics Ltd., IDrops, Ivantis, Inc., Iantrek, Inc., Long Bridge Medical Inc., Perfect Lens LLC, RxSight, Inc. & ViewPoint
Equity owner
Eyenovia, Inc., Orasis Pharmaceuticals Ltd, Presbyopia Therapies LLC, Surface, Versant Ventures & Visionary Ventures
Consultant
Carl Zeiss Meditec, Johnson & Johnson Vision Care, Inc. & JelliSee Ophthalmics Inc.
Royalty
Slack
Victoria Chen
None
Amy Coburn, MD
None
Marcus H. Colyer, MD
Ownership/Executive
Covalent Medical, LLC
Craig Czyz, DO, FACS
None
Brett Davies, MD
None
Uday Devgan, MD, FACS
Owner
CataractCoach.com
Stockholder
Advanced Euclidean Solutions LLC & IOLcalc.com
Speaker
Alcon Vision LLC
Asad F. Durrani
None
Carmen Gentile
None
Ashok K. Grover, MD, MNAMS, FRCS, FICO, FAICO
None
Annette Hoskin, MBA, MS
Employee
Essilor International
Maggie Hymowitz, MD
None
Yunia Irawati
None
Grant Justin, MD
None
Donna Kim, MD
None
Ferenc Kuhn, MD, PhD
None
Meera Lakshmi
None
Nicole Legare
None
Gary Legault, MD
None
Jennifer I. Lim, MD
Consultant
Genentech, Inc., Cognition Therapeutics, Regeneron Pharmaceuticals Inc., Novartis AG, Eyenuk, Inc. & IVERIC bio, Inc.
DMC Consultant
Santen Pharmaceutical Co., Ltd., Quark Pharmaceuticals, Inc., Aura Biosciences, Inc., Opthea & Luxa
Clinical Trial Studies/Grants
Genentech, Inc., Chengdu, Regeneron Pharmaceuticals Inc., NGM Biopharmaceuticals, Aldeyra Therapeutics, Inc., Stealth BioTherapeutics Inc. & Graybug Vision, Inc.
Alice C. Lorch, MD, MPH
None
Anthony C. Maida
None
Rutuja Malekar
None
Janice Maliakkal
None
Robert A. Mazzoli, MD, FACS
None
Sarah Miller
None
Ann P. Murchison, MD, MPH
Research
GlaxoSmithKline plc
Sonam Nisar
None
Lisa Park, MD
None
David W. Parke III, MD
None
Ron W. Pelton, MD, PhD, FACS
None
Annisa Permadi
None
Rajesh C. Rao, MD
None
Christopher J. Rapuano, MD
Consultant
Avellino Lab, Bio-Tissue, Inc., Celularity Inc., Oyster Point Pharma, Inc., Tarsus Pharmaceuticals, Inc. & TearLab Corporation
Consultant/Speaker
Dompé farmaceutici S.p.A. &
Glaukos Corporation
Allison E. Rizzuti, MD
None
Daniel Rodricks
None
Andrés M. Rousselot Ascarza, MD
Podcast recording
ELEA – Argentina
Ankoor Shah, MD, PhD
Stock
Pfizer Inc. & Medtronic
Royalties
Rebion
Yesha Shah
None
Gangadhara Sundar, DO, FRCSEd, FAMS, AB
None
Kamil Taneja
None
Marisa Tieger
None
Joshua H. Uhr
Consultant
Alimera Sciences, Inc.
Siri Uppuluri
None
Lejla Vajzovic, MD
Investigator
Applied Genetic Technologies Corporation, Aldeyra Therapeutics, Inc., Heidelberg Engineering GmbH, REGENXBIO Inc.,
Investigator/Consultant
Alcon Vision LLC, Gyroscope Therapeutics/ Orbit Biomedical, Novartis AG, & F. Hoffmann-La Roche AG/Genentech, Inc.
Consultant
Alimera Sciences, Inc., Allergan plc, Bausch & Lomb Incorporated, Beaver- Visitec International, Inc., Dutch Ophthalmic Research Center B.V., Guidepoint Global, LLC & OCULUS Surgical, Inc.
Speaker
Evolve Medical Education
Hursuong Vongsachang
None
Fasika Woreta, MD, MPH
None
Yoshihiro Yonekawa, MD
Consultant
Alcon Vision LLC, Genentech, Inc., Allergan & Alimera SciencesAll of the relevant financial relationships listed for these individuals have been mitigated.
PLEASE NOTE: You need to register with Accelevents to access this event.
You will receive your registration email from Accelevents. Click "Join the Event" to return to this page where you will see the option to 'Enter Event' at 9:30am EDT.
Presentations will begin on the Stage at 10:00am EDT.
PLEASE NOTE: You need to register with Accelevents to access this event.
You will receive your registration email from Accelevents. Click "Join the Event" to return to this page where you will see the option to 'Enter Event' at 9:30am EDT.
Presentations will begin on the Stage at 10:00am EDT.